By Jim Reilly, Vice President, Vault R&D, Veeva Systems, Inc.
In response to the pandemic, the industry made Herculean efforts to minimize disruption and (in some cases) speed product development last year. From simpler trial designs and faster protocol development to decentralized trials and new regulatory approval pathways, there have been countless examples of pharma companies and health authorities coming together to innovate and collaborate more efficiently.
While COVID-19 brought great chaos and crises last year, it also fueled incredible innovation and collaboration across the life sciences industry. Learn how digital acceleration will reinvent the clinical trial landscape in 2021.